Follow the 동국생명과학 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 동국생명과학 has logged 1 insider filings. Market capitalisation: €76.1bn. The latest transaction was filed on 9 April 2026 (Purchase). Among the most active insiders: 김영선. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Dongguk Life Science 是一家专注于健康和制药领域的公司,在 XKRX 市场上市。它专注于生物制药产品的开发和制造。